SynthesisFrontiers in immunology2022

Efficacy and safety of rituximab treatment in patients with idiopathic inflammatory myopathies: A systematic review and meta-analysis.

Chao Zhen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.